LN

Lakshmi Neelima Yelluri

Active Director Designated Partner DIN 10287474
DIN 10287474 First appointment Aug 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Lakshmi Neelima Yelluri

Data last updated:

Lakshmi Neelima Yelluri is a Designated Partner at Clinospark Clinical Research Llp (since 2023). The company operates in Healthcare.

DIN 10287474
Primary Designation Designated Partner
Industry Healthcare
First Appointment 21 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Aug 20232023Active

Board colleagues of Lakshmi Neelima Yelluri

NameDINCompanyDesignation
Eluri Venkata Kanaka Durga Suseela10287475Clinospark Clinical Research LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Clinospark Clinical Research Llp
Premium access

Shareholding and investment profile for Lakshmi Neelima Yelluri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lakshmi Neelima Yelluri

Lakshmi Neelima Yelluri currently holds 1 directorship: Clinospark Clinical Research Llp (Designated Partner, since 21 Aug 2023).

Lakshmi Neelima Yelluri was first appointed on 21 Aug 2023 as Designated Partner at Clinospark Clinical Research Llp.

The current boards of Lakshmi Neelima Yelluri's companies include Eluri Venkata Kanaka Durga Suseela (Clinospark Clinical Research Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available